Charles River Announces Rare Disease Gene Therapy Collaborat

HQ plasmid DNA production to support Phase I trials for gene therapy targeting Bardet-Biedl Syndrome

...

Related Keywords

, Andrew Frazer , Kerstin Dolph , Victor Hernandez , Axovia Therapeutics Ltd , Manufacturing Services , Scientific Solutions , Charles River Laboratories International Inc , Charles River Laboratories International , Axovia Therapeutics , Charles River , High Quality , Bardet Biedl Syndrome , Rare Pediatric Disease , Associate Director , Gene Therapy , Corporate Senior Vice President , Global Manufacturing , Chief Scientific Officer ,